ENZ - ENZO BIOCHEM （）

FARMINGDALE, N.Y. (AP) — FARMINGDALE, N.Y. (AP) — Enzo Biochem Inc. (ENZ) on Monday reported a loss of $11.3 million…

Enzo Biochem press release (ENZ): Q2 GAAP EPS of -$0.23.Revenue of $16.34M (-52.0% Y/Y).

Gainers Enzo Biochem, Inc. (NYSE: ENZ ) gained 86.5% to $2.22 after the company announced it will sell its clinical laboratory to Labcorp. Histogen Inc. (NASDAQ: HSTO ) climbed 60% to $1.39 after the company announced issuance of a US patent covering CTS-2090 methods of use. QualTek Services Inc. (NASDAQ: QTEK ) gained 56.4% to $0.4379. QualTek secured new money financing. AirNet Technology Inc. (NASDAQ: ANTE ) climbed 38.3% to $1.12. Maxpro Capital Acquisition Corp. (NASDAQ: JMAC ) gained 38% to $13.66. Lixiang Education Holding Co., Ltd. (NASDAQ: LXEH ) jumped 28% to $1.25. Traeger, Inc. (NYSE: COOK ) gained 24% to $3.7415 after the company announced better-than-expected Q4 results. AppTech Payments Corp. (NASDAQ: APCX ) jumped 22.8% to $1.5350. Aclarion, Inc. (NASDAQ: ACON ) gained 20% to $0.83. Berkshire Grey, Inc. (NASDAQ: BGRY ) climbed 18.3% to $1.16. Meihua International Medical Technologies Co., Ltd. (NASDAQ: MHUA ) jumped 18% to $15.98 Paranovus Entertainment Technology Ltd.

Gainers: Enzo Biochem (ENZ) +85%. Traeger (COOK) +25%

U.S. stocks traded lower midway through trading, with the Dow Jones dropping more than 300 points on Friday. The Dow traded down 1.07% to 31,899.93 while the NASDAQ fell 0.68% to 11,638.13. The S&P 500, also fell, dropping, 0.94% to 3,923.10. Check This Out: Top 5 Tech Stocks Which You''ll Regret Missing This Quarter Leading and Lagging Sectors Information technology shares fell by just 0.02% on Friday. Meanwhile, top gainers in the sector included WM Technology, Inc. (NASDAQ: MAPS ), up 14%, and Riot Platforms, Inc. (NASDAQ: RIOT ), up 11%. In trading on Thursday, financials shares dipped by 2.8%. Top Headline Industrial production came in unchanged for February, following a 0.3% increase in January. Equities Trading UP Enzo Biochem, Inc. (NYSE: ENZ ) shares shot up 86% to $2.21 after the company announced it will sell its clinical laboratory … Full story available on Benzinga.com

In last trading session, Enzo Biochem Inc. (NYSE:ENZ) saw 0.36 million shares changing hands with its beta currently measuring 0.79. Company’s recent per share price level of $1.33 trading at $0.17 or 14.66% at ring of the bell on the day assigns it a market valuation of $65.50M. That closing price of ENZ’s stock is … Enzo Biochem Inc. (NYSE:ENZ) Down Almost -36.67% In 1 Month, Long Term Looking Good As Well Read More »

Enzo Biochem, Inc. (NYSE:NYSE:ENZ) Q1 2023 Earnings Conference Call December 13, 2022 08:30 A.M.

- Enzo Life Sciences reports revenue of $7.1 million and 9% growth in Q1 FY 2023, excluding FX - Engagement with investment bank to provide advisory services including the evaluation of strategic alternatives for the Company is progressing well. - Continuing to make progress in market expansion of the current product portfolio, commercialization of the Company’s offerings, and optimization of

Major players in the renal biomarkers market are Abbott Laboratories, BioPorto Diagnostics A/S, Roche Holding AG, Thermo Fisher Scientific, bioMérieux SA, Randox Laboratories, Siemens Healthineers, Beckman Coulter, Astute Medical Inc, Nexelis, Sphingotec GmbH, Bio-Rad Laboratories, Enzo Biochem Inc. Major players in the renal biomarkers market are Abbott Laboratories, BioPorto Diagnostics A/S, Roche Holding AG, Thermo Fisher Scientific, bioMérieux SA, Randox Laboratories, Siemens Healthineers, Beckman Coulter, Astute Medical Inc, Nexelis, Sphingotec GmbH, Bio-Rad Laboratories, Enzo Biochem Inc.

Enzo Biochem press release (ENZ): Q4 Non-GAAP EPS of -$0.17.Revenue of $20.28M (-18.2% Y/Y).

Enzo Biochem press release (ENZ): Q4 Non-GAAP EPS of -$0.17.Revenue of $20.28M (-18.2% Y/Y).

Gainers Panbela Therapeutics, Inc. (NASDAQ: PBLA ) shares jumped 53% to close at $0.58 on Friday. Applied Optoelectronics, Inc. (NASDAQ: AAOI ) shares climbed 50.4% to settle at $3.76 on Friday after the company announced the sale of its Chinese manufacturing facilities to Yuhan Optoelectronic Technology for $150 million. iBio, Inc. (NYSE: IBIO ) gained 49.8% to close at $0.46. Armata Pharmaceuticals, Inc. (NYSE: ARMP ) surged 31.2% to close at $4.21. Armata Pharmaceuticals, last month, posted a Q2 loss of $0.26 per share. Axcella Health Inc. (NASDAQ: AXLA ) jumped 29.6% to close at $2.41. Axcella Health, last month, posted a Q2 loss of $0.40 per share. Anixa Biosciences, Inc. (NASDAQ: ANIX ) gained 27.5% to close at $5.71. Lannett Company, Inc. (NYSE: LCI ) gained 25.1% to close at $0.5756. Lannett Company, last month, reported Q4 FY22 sales of $74.2 million, down from $106 million a year ago Integrated Media Technology Limited (NASDAQ: IMTE ) climbed 21.5% to close at $1.75. Decisionpoint Systems, Inc. (NASDAQ: DPSI ) rose 20.8% to close at $5.93.

On June 9, Enzo Biochem announced a new strategic review that can finally lead to the sale of the long-mismanaged company. See more on ENZ stock here.

Enzo Biochem, Inc. (NYSE:NYSE:ENZ) Q3 2022 Earnings Conference Call June 10, 2022 8:30 AM ET Company Participants Chris Calabrese - Investor Relations Hamid Erfanian - Chief Executive…

Enzo Biochem press release (ENZ): Q3 GAAP EPS of -$0.10.Revenue of $26.2M (-20.1% Y/Y).Adjusted EBITDA loss in the 3Q of $1.8M, compared to adjusted EBITDA of $2.7M in the 3Q of…